Medcompare - The Buyer's Guide for Medical Professionals Urology Buyer's Guide
Products New Products News Journal Updates Articles Resources Events
Search Medcompare
Enter Keyword(s):


Advertisement
Adult Diapers
Articles
InterStim Therapy in Voiding Dysfunction
InterStim Therapy in Voiding Dysfunction
Advertisement
> > > Free Testosterone EIA Test

Free Testosterone EIA Test

General Information
VendorDiagnostic Systems Laboratories, Inc.
ItemFree Testosterone EIA Test
Catalog NumberDSL-10-49100
Size96 wells
Range7, 0.25 - 100 pg/mL
Sample TypeSerum
Regulatory StatusFor In Vitro Diagnostic Use
DisciplineEIA
Sensitivity 0.19 pg/mL
Incubation Time1 hr + 30 mins + 30 mins on shaker at RT
PricingInquire
Product Description
Only 1-2% of circulating testosterone exists as unbound or free testosterone. The majority, approximately 60%, is bound to SHBG with high affinity [1], while the remainder is loosely bound to albumin. Both the albumin-bound and free fractions may be biologically active, while SHBG effectively inhibits testosterone action. Measurement of the free or unbound fraction of serum testosterone has been proposed as a means of estimating the physiologically bioactive hormone. Free testosterone levels are elevated in women with hyperandrogenism associated with hirsutism in the presence or absence of polycystic ovarian disease [1,2,3]. In addition, free testosterone measurements may be more useful than total testosterone in situations where SHBG is increased or decreased (e.g. hypothyroidism, obesity and hyperinsulism).

Traditional methods for measurement of free testosterone involve the use [3H]-testosterone combined with labor-intensive separation techniques to calculate bound and free fractions. The DSL method, however, utilizes an I-125 labeled testosterone analog which has low affinity for SHBG and albumin for direct estimation of unlabeled free testosterone levels in unextracted samples.

  1. Cumming DC & Wall SR. J Clin Endocrinol Metab 61:873-876, 1985.
  2. Westphal U. Steroid-Protein Interactions. Springer-Verlag, Berlin, 1986
  3. Pugeat M, et al.: Androgens in polycystic ovarian syndrome. IN Tolis G, Bringer J, Chrousos GP (eds): Intraovarian regulators and polycystic ovarian syndrome. NY Academy of Sciences, New York, 1993, pp. 124-135.
View Vendor Contact Information
NOTE: Medcompare disclaims any information on this site. The information found on Medcompare (Drug Guide, Product Listings and otherwise) is intended for use by medical professionals. This information is not intended to replace the information, advice or instructions from a medical doctor. Pricing information is approximate, actual prices may vary.